Tool evaluation for the detection of variably sized indels from next generation whole genome and targeted sequencing data

PLoS Comput Biol. 2022 Feb 17;18(2):e1009269. doi: 10.1371/journal.pcbi.1009269. eCollection 2022 Feb.

Abstract

Insertions and deletions (indels) in human genomes are associated with a wide range of phenotypes, including various clinical disorders. High-throughput, next generation sequencing (NGS) technologies enable the detection of short genetic variants, such as single nucleotide variants (SNVs) and indels. However, the variant calling accuracy for indels remains considerably lower than for SNVs. Here we present a comparative study of the performance of variant calling tools for indel calling, evaluated with a wide repertoire of NGS datasets. While there is no single optimal tool to suit all circumstances, our results demonstrate that the choice of variant calling tool greatly impacts the precision and recall of indel calling. Furthermore, to reliably detect indels, it is essential to choose NGS technologies that offer a long read length and high coverage coupled with specific variant calling tools.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Computational Biology* / methods
  • Genome, Human / genetics
  • High-Throughput Nucleotide Sequencing / methods
  • Humans
  • INDEL Mutation* / genetics
  • Polymorphism, Single Nucleotide / genetics

Grants and funding

N.W. has received funding from the Turku University Foundation (https://www.yliopistosaatio.fi/en/). K.O. has received funding from State Research Funding from the Turku University Hospital (https://www.vsshp.fi/en/tutkijoille/rahoitus/Pages/default.aspx). L.L.E. reports grants from the European Research Council ERC (677943) (https://erc.europa.eu/), Academy of Finland (296801, 310561, 314443, 329278, 335434, 335611) (https://www.aka.fi/en/), and Sigrid Juselius Foundation (https://www.sigridjuselius.fi/en/), during the conduct of the study. Our research is also supported by University of Turku Graduate School (UTUGS), Biocenter Finland, and ELIXIR Finland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.